Viral immune monitoring for post-transplant lymphoproliferative disorder: Editorial

Pediatric Transplantation

Volumn 13, Issue 5, 2009, Pages 521-523

  Dharnidharka, Vikas ^a   Gupta, Sushil ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4+ T LYMPHOCYTE; CYTOMEGALOVIRUS; EDITORIAL; EPSTEIN BARR VIRUS; HUMAN; LYMPHOPROLIFERATIVE DISEASE; PATIENT MONITORING; POLYMERASE CHAIN REACTION; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; VIRUS LOAD;

ADENOSINE TRIPHOSPHATE; CD4-POSITIVE T-LYMPHOCYTES; CHILD; GRAFT REJECTION; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; LYMPHOCYTES; LYMPHOPROLIFERATIVE DISORDERS; POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

EID: 67651152940     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2009.01144.x     Document Type: Editorial

References (20)

1. Dharnidharka VR, Stablein DM, Harmon WE. Post-transplant infections now exceed acute rejection as cause for hospitalization: A report of the NAPRTCS. Am J Transplant 2004 : 3 : 384 389.
2. Dharnidharka VR, Tejani AH, Ho PL, Harmon WE. Post-transplant lymphoproliferative disorder in the United States: Young Caucasian males are at highest risk. Am J Transplant 2002 : 10 : 993 998.
3. Opelz G, Dohler B. Lymphomas after solid organ transplantation: A collaborative transplant study report. Am J Transplant 2004 : 2 : 222 230.
4. Nickerson P, Jeffery J, Rush D. Long-term allograft surveillance: The role of protocol biopsies. Curr Opin Urol 2001 : 2 : 133 137.
5. Rush D, Nickerson P, Jeffery J. Protocol biopsies in the management of renal allograft recipients. Curr Opin Nephrol Hypertens 2000 : 6 : 615 619.
6. Elidemir O, Kancherla B, Schecter M, et al. Post-transplant lymphoproliferative disease in pediatric lung transplant recipients: Recent advances in monitoring. Pediatr Transplant in press 2009 : doi
7. Holmes RD, Orban-Eller K, Karrer FR, Rowe DT, Narkewicz MR, Sokol RJ. Response of elevated Epstein-Barr virus DNA levels to therapeutic changes in pediatric liver transplant patients: 56-month follow up and outcome. Transplantation 2002 : 3 : 367 372.
8. Tsai DE, Douglas L, Andreadis C, et al. EBV PCR in the diagnosis and monitoring of posttransplant lymphoproliferative disorder: Results of a two-arm prospective trial. Am J Transplant 2008 : 5 : 1016 1024.
9. Schubert S, Renner C, Hammer M, et al. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients. J Heart Lung Transplant 2008 : 1 : 100 105.
10. Green M, Bueno J, Rowe D, et al. Predictive negative value of persistent low Epstein-Barr virus viral load after intestinal transplantation in children. Transplantation 2000 : 4 : 593 596.
11. Mcdiarmid SV, Jordan S, Kim GS, et al. Prevention and preemptive therapy of posttransplant lymphoproliferative disease in pediatric liver recipients. Transplantation 1998 : 12 : 1604 1611.
12. Green M, Webber SA. Persistent increased Epstein-Barr virus loads after solid organ transplantation: Truth and consequences? Liver Transpl 2007 : 3 : 321 322.
13. Bingler MA, Feingold B, Miller SA, et al. Chronic high Epstein-Barr viral load state and risk for late-onset posttransplant lymphoproliferative disease/lymphoma in children. Am J Transplant 2008 : 2 : 442 445.
14. Henry DD, Hunger SP, Braylan RC, Dharnidharka VR. Low viral load post-transplant lymphoproliferative disease localized within the tongue. Transpl Infect Dis 2008 : 6 : 426 430.
15. Lee TC, Savoldo B, Rooney CM, et al. Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients. Am J Transplant 2005 : 9 : 2222 2228.
16. Benden C, Aurora P, Burch M, et al. Monitoring of Epstein-Barr viral load in pediatric heart and lung transplant recipients by real-time polymerase chain reaction. J Heart Lung Transplant 2005 : 12 : 2103 2108.
17. Michelson P, Watkins B, Webber SA, Wadowsky R, Michaels MG. Screening for PTLD in lung and heart-lung transplant recipients by measuring EBV DNA load in bronchoalveolar lavage fluid using real time PCR. Pediatr Transplant 2008 : 4 : 464 468.
18. Kowalski R, Post D, Schneider MC, et al. Immune cell function testing: An adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant 2003 : 2 : 77 88.
19. Hooper E, Hawkins DM, Kowalski RJ, et al. Establishing pediatric immune response zones using the Cylex ImmuKnow assay. Clin Transplant 2005 : 6 : 834 839.
20. Israeli M, Klein T, Sredni B, et al. ImmuKnow: A new parameter in immune monitoring of pediatric liver transplantation recipients. Liver Transpl 2008 : 6 : 893 898.